link.springer.com

Effects of Methylphenidate and Bupropion on DHEA-S and Cortisol Plasma Levels in Attention-deficit Hyperactivity Disorder - Child Psychiatry & Human Development

  • ️Jung, In-Kwa
  • ️Fri Aug 31 2007

  • Elia J, Ambrosini PJ, Rapoport JL (1999) Treatment of attention-deficit-hyperactivity disorder. N Engl J␣Med 340(10):780–788

    Article  PubMed  Google Scholar 

  • Arnsten AF (2006) Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J␣Clin Psychiatry 67(Suppl 8):7–12

    PubMed  Google Scholar 

  • Timimi S, Taylor E (2004) ADHD is best understood as a cultural construct. Br J Psychiatry 184:8–9

    Article  PubMed  Google Scholar 

  • Dubrovsky BO (2005) Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog Neuropsychopharmacol Biol Psychiatry 29(2):169–192

    Article  PubMed  Google Scholar 

  • Strous RD, Spivak B, Yoran-Hegesh R, Maayan R, Averbuch E, Kotler M et al (2001) Analysis of neurosteroid levels in attention deficit hyperactivity disorder. Int J Neuropsychopharmacol 4(3):259–264

    Article  PubMed  Google Scholar 

  • Maayan R, Yoran-Hegesh R, Strous R, Nechmad A, Averbuch E, Weizman A et al (2003) Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder. Neuropsychobiology 48(3):111–115

    Article  PubMed  Google Scholar 

  • Charalampopoulos I, Dermitzaki E, Vardouli L, Tsatsanis C, Stournaras C, Margioris AN et al (2005) Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization. Endocrinology 146(8):3309–3318

    Article  PubMed  Google Scholar 

  • Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS et al (1998) Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155(10):1325–1331

    PubMed  Google Scholar 

  • Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283(5400):397–401

    Article  PubMed  Google Scholar 

  • Ferris RM, Tang FL (1979) Comparison of the effects of the isomers of amphetamine, methylphenidate and deoxypipradrol on the uptake of l-[3H]norepinephrine and [3H]dopamine by synaptic vesicles from rat whole brain, striatum and hypothalamus. J Pharmacol Exp Ther 210(3):422–428

    PubMed  Google Scholar 

  • Challman TD, Lipsky JJ (2000) Methylphenidate: its pharmacology and uses. Mayo Clin Proc 75(7):711–721

    Article  PubMed  Google Scholar 

  • Pliszka SR (2005) The neuropsychopharmacology of attention-deficit/hyperactivity disorder. Biol Psychiatry 57(11):1385–1390

    Article  PubMed  Google Scholar 

  • Barrickman LL, Perry PJ, Allen AJ, Kuperman S, Arndt SV, Herrmann KJ et al (1995) Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34(5):649–657

    Article  PubMed  Google Scholar 

  • Conners CK, Casat CD, Gualtieri CT, Weller E, Reader M, Reiss A et al (1996) Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 35(10):1314–1321

    Article  PubMed  Google Scholar 

  • Rosenfeld RS, Hellman L, Gallagher TF (1972) Metabolism and interconversion of dehydroisoandrosterone and dehydroisoandrosterone sulfate. J Clin Endocrinol Metab 35(2):187–193

    Article  PubMed  Google Scholar 

  • Longcope C (1996) Dehydroepiandrosterone metabolism. J Endocrinol 150(Suppl):S125–127

    PubMed  Google Scholar 

  • DuPaul GJ, Power TJ, Anastopoulos AD, Reid R (1998) The ADHD Rating Scale-IV: Checklists, norms, and clinical interpretation. Guilford Press, New York

    Google Scholar 

  • So YK, Noh JS, Kim YS, Ko SG, Koh Y-J (2002) The reliability and validity of Korean parent and teacher ADHD rating scale. J Korean Neuropsychiatr Assoc 41(2):283–289

    Google Scholar 

  • Shin MS, Cho S, Chun SY, Hong K-E (2000) A study of the development and standardization of ADHD diagnostic system. Korean J Child Adol Psychiatr 11(1):91–99

    Google Scholar 

  • Salek FS, Bigos KL, Kroboth PD (2002) The influence of hormones and pharmaceutical agents on DHEA and DHEA-S concentrations: a review of clinical studies. J Clin Pharmacol 42(3):247–266

    Article  PubMed  Google Scholar 

  • Strous RD, Maayan R, Lapidus R, Stryjer R, Lustig M, Kotler M et al (2003) Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry 60(2):133–141

    Article  PubMed  Google Scholar 

  • Demirgoren S, Majewska MD, Spivak CE, London ED (1991) Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor. Neuroscience 45(1):127–135

    Article  PubMed  Google Scholar 

  • Bergeron R, de Montigny C, Debonnel G (1996) Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors. J␣Neurosci 16(3):1193–1202

    PubMed  Google Scholar 

  • Lehohla M, Kellaway L, Russell VA (2004) NMDA receptor function in the prefrontal cortex of a rat model for attention-deficit hyperactivity disorder. Metab Brain Dis 19(1–2):35–42

    Article  PubMed  Google Scholar 

  • Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J (1996) Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J Clin Endocrinol Metab 81(11):3951–3960

    Article  PubMed  Google Scholar